Evidence map›Paper›PMID 36936425›Full record

ArticleFrontiers in genetics2023

ACER2 forms a cold tumor microenvironment and predicts the molecular subtype in bladder cancer: Results from real-world cohorts.

Jinhui Liu, Chunliang Cheng, Tiezheng Qi, Jiatong Xiao, Weimin Zhou, Dingshan Deng, Yuanqing Dai

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jinhui LiuDepartment of Urology, Xiangya Hospital, Central South University, Changsha City, China.
Chunliang ChengDepartment of Urology, Xiangya Hospital, Central South University, Changsha City, China.
Tiezheng QiXiangya School of Medicine, Central South University, Changsha, China.
Jiatong XiaoDepartment of Urology, Xiangya Hospital, Central South University, Changsha City, China.
Weimin ZhouDepartment of Urology, Xiangya Hospital, Central South University, Changsha City, China.
Dingshan DengDepartment of Urology, Xiangya Hospital, Central South University, Changsha City, China.
Yuanqing DaiDepartment of Urology, Xiangya Hospital, Central South University, Changsha City, China.
Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACER2bladder cancerChemothearpyImmunothrapytumor micro environment

Identifiers

PMID36936425
PMCPMC10014737
OpenAlexW4322744422

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read18
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.